Evidence map›Paper›PMID 31905619›Full record

ArticleNanomaterials (Basel, Switzerland)2019

Laser-Ablative Synthesis of Isotope-Enriched Samarium Oxide Nanoparticles for Nuclear Nanomedicine.

Elena Popova-Kuznetsova, Gleb Tikhonowski, Anton A Popov, Vladimir Duflot, Sergey Deyev, Sergey Klimentov, Irina Zavestovskaya, Paras N Prasad, Andrei V Kabashin

Abstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Elena Popova-KuznetsovaBionanophotonic Lab., Institute of Engineering Physics for Biomedicine (PhysBio), National Nuclear Research University MEPHI, Moscow 115409, Russia.
Gleb TikhonowskiBionanophotonic Lab., Institute of Engineering Physics for Biomedicine (PhysBio), National Nuclear Research University MEPHI, Moscow 115409, Russia.
Anton A PopovBionanophotonic Lab., Institute of Engineering Physics for Biomedicine (PhysBio), National Nuclear Research University MEPHI, Moscow 115409, Russia.
Vladimir DuflotKarpov Institute of Physical Chemistry, NIFKhI, Obninsk 249033, Kaluga region, Russia.
Sergey DeyevBionanophotonic Lab., Institute of Engineering Physics for Biomedicine (PhysBio), National Nuclear Research University MEPHI, Moscow 115409, Russia.
Sergey KlimentovBionanophotonic Lab., Institute of Engineering Physics for Biomedicine (PhysBio), National Nuclear Research University MEPHI, Moscow 115409, Russia.
Irina ZavestovskayaBionanophotonic Lab., Institute of Engineering Physics for Biomedicine (PhysBio), National Nuclear Research University MEPHI, Moscow 115409, Russia.
Paras N PrasadBionanophotonic Lab., Institute of Engineering Physics for Biomedicine (PhysBio), National Nuclear Research University MEPHI, Moscow 115409, Russia.
Andrei V KabashinBionanophotonic Lab., Institute of Engineering Physics for Biomedicine (PhysBio), National Nuclear Research University MEPHI, Moscow 115409, Russia.ORCID 0000-0003-1549-7198

Funding

MEPhI Academic Excellence Project 02.a03.21.0005Russian Science Foundation 19-72-30012State Atomic Energy Corporation ROSATOM 313/1655-D
6 · The paper itself

Abstract

Nuclear nanomedicine is an emerging field, which utilizes nanoformulations of nuclear agents to increase their local concentration at targeted sites for a more effective nuclear therapy at a considerably reduced radiation dosage. This field needs the development of methods for controlled fabrication of nuclear agents carrying nanoparticles with low polydispersity and with high colloidal stability in aqueous dispersions. In this paper, we apply methods of femtosecond (fs) laser ablation in deionized water to fabricate stable aqueous dispersion of

Indexed as

femtosecond laser ablation and fragmentationnuclear nanomedicinepulsed laser ablation in liquidssamarium (Sm) oxide nanoparticles

Identifiers

PMID31905619
PMCPMC7022655

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.